Literature DB >> 7604206

Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors.

J Fujimoto1, S Ichigo, M Hori, M Nishigaki, T Tamaya.   

Abstract

This study was designed to examine the biological implication of progesterone receptor (PR) forms A and B mRNA expressions in gynecologic cancers. The ratio of PR form A to form B in mRNA expression was approximately 1:1 in all endometria studied. The predominant expressions of form B transcript occurred in 6 out of 7 cases of advanced stages (stages III and IV) in ovarian cancers, in 5 out of 9 cases of cervical cancers, and in 5 out of 11 cases of endometrial cancers. In conclusions, the dominancy of PR form B mRNA expression might be associated with the expression of a malignant phenotype in gynecologic cancers, and advanced clinical stage in ovarian cancers, suggesting a biological marker of malignant phenotype in these three types of cancer cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604206     DOI: 10.1159/000217942

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  14 in total

Review 1.  Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.

Authors:  Margeaux Wetendorf; Francesco J DeMayo
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

2.  Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.

Authors:  Nikki L Neubauer; Erin C Ward; Parin Patel; Zhenxiao Lu; Irene Lee; Leen J Blok; Payman Hanifi-Moghaddam; Julian Schink; J Julie Kim
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

Review 3.  Progesterone: the ultimate endometrial tumor suppressor.

Authors:  Shujie Yang; Kristina W Thiel; Kimberly K Leslie
Journal:  Trends Endocrinol Metab       Date:  2011-02-25       Impact factor: 12.015

Review 4.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

5.  Progesterone receptor isoform identification and subcellular localization in endometrial cancer.

Authors:  Kimberly K Leslie; Mary-Pat Stein; Nirmala S Kumar; Donghai Dai; Janet Stephens; Angela Wandinger-Ness; Deborah H Glueck
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

6.  Disrupted cell cycle control in cultured endometrial cells from patients with endometriosis harboring the progesterone receptor polymorphism PROGINS.

Authors:  Paulo D'Amora; Thiago Trovati Maciel; Rodrigo Tambellini; Marcelo A Mori; João Bosco Pesquero; Helio Sato; Manoel João Batista Castello Girão; Ismael Dale Cotrim Guerreiro da Silva; Eduardo Schor
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

7.  The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.

Authors:  Erin C Ward; Anna V Hoekstra; Leen J Blok; P Hanifi-Moghaddam; John R Lurain; Diljeet K Singh; Barbara M Buttin; Julian C Schink; J Julie Kim
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

Review 8.  Role of progesterone in endometrial cancer.

Authors:  J Julie Kim; Eloise Chapman-Davis
Journal:  Semin Reprod Med       Date:  2010-01-26       Impact factor: 1.303

Review 9.  Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.

Authors:  Md Soriful Islam; Sadia Afrin; Sara Isabel Jones; James Segars
Journal:  Endocr Rev       Date:  2020-10-01       Impact factor: 19.871

10.  Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo.

Authors:  Petr Horak; Michal Mara; Pavel Dundr; Kristyna Kubinova; David Kuzel; Robert Hudecek; Roman Chmel
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.